Lv1
20 积分 2025-11-19 加入
Immune checkpoint inhibitors in melanoma
3个月前
已完结
The Challenge of Treating Anti-PD-1-Resistant Advanced Melanoma
3个月前
已完结
A review of the efficacy of prostate cancer therapies against castration-resistant prostate cancer
4个月前
已完结
Dynamic blood-based biomarkers predict early response to ipilimumab and nivolumab in advanced melanoma
4个月前
已完结
Survival of patients with advanced metastatic melanoma: The impact of novel therapies
5个月前
已完结
Cancer treatment and survivorship statistics, 2025
5个月前
已完结
Gaining momentum: New options and opportunities for the treatment of advanced melanoma
5个月前
已完结
Revolutionizing treatment of advanced melanoma with immunotherapy
5个月前
已完结
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
5个月前
已完结
Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date
5个月前
已完结
皖公网安备34019202002308
